Comparison

Desmorpholinyl Navitoclax-NH-Me European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 10mM/1mL
Quantity options 100 mg 10mM/1mL 10 mg 50 mg 5 mg
Item no. HY-131232-10mM
CASRN 2365172-82-1
eClass 6.1 30220300
eClass 9.0 32160605
Available
Alias Desmorpholinyl ABT-263-NH-Me
Purity 98.64
Product Description
Desmorpholinyl Navitoclax-NH-Me is a Bcl-xL inhibitor. Desmorpholinyl Navitoclax-NH-Me and a CRBN ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC BCL-XL degrader XZ739 (HY-133557)[1][2].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
918.55
Clinical_Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target
Bcl-2 Family; Ligands for Target Protein for PROTAC
Pathway
Apoptosis; PROTAC

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close